B A Hutten

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. pmc Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study
    Anne Cornelie J M de Pont
    Department of Intensive Care, Academic Medical Center, University of Amsterdam, The Netherlands
    Crit Care 9:R490-7. 2005
  2. ncbi request reprint Safety of treatment with oral anticoagulants in the elderly. A systematic review
    B A Hutten
    Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, The Netherlands
    Drugs Aging 14:303-12. 1999
  3. ncbi request reprint Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists
    B A Hutten
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, The Netherlands
    Thromb Haemost 82:1260-3. 1999
  4. ncbi request reprint Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis
    B A Hutten
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, The Netherlands
    J Clin Oncol 18:3078-83. 2000
  5. ncbi request reprint The use of lipid-lowering drug therapy in children and adolescents
    Hans J Avis
    University of Amsterdam, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Meibergdreef 9, Amsterdam, The Netherlands
    Curr Opin Investig Drugs 10:224-31. 2009
  6. ncbi request reprint Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism
    P M Kuijer
    Center for Haemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, University of Amsterdam, The Netherlands
    Arch Intern Med 159:457-60. 1999
  7. ncbi request reprint Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome
    C J J van Dongen
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, Netherlands
    J Thromb Haemost 3:939-42. 2005
  8. ncbi request reprint The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism
    D Haverkamp
    Department of Clinical Epidemiology, Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 1:69-73. 2003
  9. pmc Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial
    L Jakulj
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    J Lipid Res 51:755-62. 2010
  10. ncbi request reprint Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor
    H M Otten
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Haemostasis 30:72-6; discussion 63. 2000

Collaborators

Detail Information

Publications26

  1. pmc Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study
    Anne Cornelie J M de Pont
    Department of Intensive Care, Academic Medical Center, University of Amsterdam, The Netherlands
    Crit Care 9:R490-7. 2005
    ..The aim of the present study was to evaluate the dynamics of the anticoagulant, anti-inflammatory and pro-fibrinolytic action of rhAPC in patients with severe sepsis, by comparing rhAPC-treated patients with case controls...
  2. ncbi request reprint Safety of treatment with oral anticoagulants in the elderly. A systematic review
    B A Hutten
    Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, The Netherlands
    Drugs Aging 14:303-12. 1999
    ..In general, if oral anticoagulant treatment is started, the lowest possible effective International Normalised Ratios (INR) should be selected and regular monitoring should be done to avoid over-anticoagulation...
  3. ncbi request reprint Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists
    B A Hutten
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, The Netherlands
    Thromb Haemost 82:1260-3. 1999
    ..Since these differences were small, linear interpolation is preferable to the hybrid method, since the calculations involved are easier...
  4. ncbi request reprint Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis
    B A Hutten
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, The Netherlands
    J Clin Oncol 18:3078-83. 2000
    ..The aim of this study was to assess the incidence of venous thromboembolic recurrence and major bleeding among patients with venous thromboembolism in relation to both malignancy and the achieved INR...
  5. ncbi request reprint The use of lipid-lowering drug therapy in children and adolescents
    Hans J Avis
    University of Amsterdam, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Meibergdreef 9, Amsterdam, The Netherlands
    Curr Opin Investig Drugs 10:224-31. 2009
    ..Nevertheless, more studies are needed to confirm the lifelong benefit of lipid-lowering therapy initiated in childhood...
  6. ncbi request reprint Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism
    P M Kuijer
    Center for Haemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, University of Amsterdam, The Netherlands
    Arch Intern Med 159:457-60. 1999
    ....
  7. ncbi request reprint Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome
    C J J van Dongen
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, Netherlands
    J Thromb Haemost 3:939-42. 2005
    ..0 and 3.0. We hypothesized that patients who spend a large amount of their time beneath this range will have an increased risk of the PTS...
  8. ncbi request reprint The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism
    D Haverkamp
    Department of Clinical Epidemiology, Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 1:69-73. 2003
    ..Although antidotes against anticoagulant treatment are widely available, our analysis shows that in only a very small number of patients a direct, or slow-acting antidote to reverse the anticoagulant effect was used...
  9. pmc Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial
    L Jakulj
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    J Lipid Res 51:755-62. 2010
    ..However, due to the exploratory nature of any posthoc analysis, these results warrant further prospective evaluation in different populations...
  10. ncbi request reprint Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor
    H M Otten
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Haemostasis 30:72-6; discussion 63. 2000
    ....
  11. ncbi request reprint Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis
    M R Hoppener
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands
    J Thromb Haemost 2:1316-20. 2004
    ..FVIII:C increases significantly after infusion of epinephrine, vasopressin or physical exercise. The aim of the present study was to investigate whether beta-receptor blockade will lower sustained elevated FVIII:C in patients with VTE...
  12. ncbi request reprint Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX
    J F van der Heijden
    Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 2:1104-9. 2004
    ..Individual patient characteristics may also influence bleeding risk. In addition, soluble thrombomodulin (s-TM) levels and mutations in the propeptide of factor (F)IX are important candidate risk factors in this respect...
  13. doi request reprint Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness
    S Sivapalaratnam
    Department of Vascular Medicine, Academic Medical Centre, F4 159 2, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Atherosclerosis 212:571-4. 2010
    ....
  14. doi request reprint Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease
    M de Fost
    Department of Internal Medicine, Division of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Atherosclerosis 204:267-72. 2009
    ..HDL-c levels are abnormally low in type I Gaucher disease (GD) patients. The aim of this study was to determine whether GD is associated with premature atherosclerosis...
  15. pmc Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia
    R Huijgen
    Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands
    J Lipid Res 53:979-83. 2012
    ..Therefore, the results of pharmaceutical inhibition of PCSK9 in FH patients are eagerly awaited...
  16. ncbi request reprint Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy
    D M Kusters
    Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Neth J Med 68:299-303. 2010
    ..This review describes two representative cases from clinical practice, and discusses clinical considerations for treating pregnant FH patients supplemented with what is known from the literature...
  17. ncbi request reprint Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome
    C H van Ommen
    Department of Pediatrics Pediatric Hematology, Emma Children s Hospital Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 1:2516-22. 2003
    ..In conclusion, congenital prothrombotic disorders seem to play a role in the development of pediatric VTE, and the risk of complications of this disease is high...
  18. ncbi request reprint A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia
    H J Avis
    Academic Medical Centre, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Arterioscler Thromb Vasc Biol 27:1803-10. 2007
    ..The purpose of this study was to assess the efficacy and particularly safety of statin therapy in children with HeFH...
  19. doi request reprint Ethnic differences in maternal total cholesterol and triglyceride levels during pregnancy: the contribution of demographics, behavioural factors and clinical characteristics
    Y J Schreuder
    Department of Public Health, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Eur J Clin Nutr 65:580-9. 2011
    ..We evaluated ethnic differences in non-fasting total cholesterol (TC) and triglyceride (TG) levels during early gestation and the role of demographics, behavioural factors and clinical characteristics...
  20. doi request reprint Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors
    Lysette N Broekhuizen
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Br J Nutr 106:1416-22. 2011
    ..Further dose-ranging studies are needed to evaluate whether and to what extent PF-rich extracts can be used to reduce the pro-inflammatory state in subjects with metabolic diseases at increased cardiovascular risk...
  21. pmc Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis
    M Nieuwdorp
    Department of Internal Medicine, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Diabetologia 50:1288-93. 2007
    ..In the present study, we evaluated the relationship between hyaluronan and hyaluronidase with carotid intima-media thickness (cIMT), an established surrogate marker for cardiovascular disease...
  22. ncbi request reprint Reduced intima media thickness in adults after prenatal exposure to the Dutch famine
    R C Painter
    Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Atherosclerosis 193:421-7. 2007
    ..Restricted prenatal growth is associated with an increased risk of coronary heart disease morbidity and mortality. We studied the effects of exposure to famine during gestation on intima media thickness (IMT) in later life...
  23. ncbi request reprint Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
    P R W de Sauvage Nolting
    Department of Vascular Medicine, Academic Medical Center Amsterdam, G1 114, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Intern Med 253:161-8. 2003
    ..Patients with familial hypercholesterolaemia (FH) vary widely in terms of onset of cardiovascular disease (CVD)...
  24. ncbi request reprint Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice
    R S Birjmohun
    Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    Neth J Med 62:229-34. 2004
    ..The inverse relation between high-density lipoprotein cholesterol (HDL-C) and cardiovascular (CV) disease underscores the need for clinical evaluation of the effect of HDL-C increasing drugs on the prevalence of CV disease...
  25. ncbi request reprint Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis
    P Prandoni
    J Thromb Haemost 5:1555. 2007
  26. ncbi request reprint The relationship between adherence and quality of treatment with vitamin K antagonists
    M Locadia
    J Thromb Haemost 2:362-3. 2004